Myriad Genetics (MYGN) Earnings Date & Reports

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individualâ€™s risk of developing a disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MYGN is expected to report earnings to fall 177.00% to 2 cents per share on July 31

Myriad Genetics MYGN Stock Earnings Reports

Q2'25

Est.

$0.02

Q1'25

Beat

by $0.03

Q4'24

Est.

$0.03

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.06

The last earnings report on May 06 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 3.87M shares outstanding, the current market capitalization sits at 1.93B.

View a ticker or compare two or three

Compare

MYGN